Drawing for EXODETECT

USPTO serial 99668351

EXODETECT

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
CRAVEN, PAUL S
Law office
TMO LAW OFFICE 126

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EXODETECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anna Kurian Shaw

Anna Kurian Shaw Hogan Lovells Cadwalader US LLP555 13TH STREET NWWashington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
010Medical diagnostic kits comprised of blood collecting tubes and blood collection needles for testing blood and detecting cancer; blood testing apparatus; containers for collecting blood samples for medical purposes; cancer screening test kit comprised primarily of blood drawing apparatus and also including containers for storing patient blood samples for analysisACTIVE—
042Diagnostic testing services, namely, providing diagnostic testing services for others for medical research and development; blood testing for scientific research purposes; providing scientific laboratory and medical research laboratory services in the field of cancerACTIVE—
044Medical testing for diagnostic or treatment purposes; medical screening; medical diagnostic testing, monitoring, and reporting services; medical testing services of blood; medical diagnostic testing services relating to the detection of cancer; medical diagnostic testing and medical analysis services related to the treatment of patients in the field of oncology; Providing information to patients in the field of medical diagnostic screening; providing medical information; providing medical diagnostic services, namely, medical analysis services for screening and diagnostic purposes provided by medical laboratories and medical diagnostic testing; providing medical information in the field of cancer screeningACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2026DOCKASSIGNED TO EXAMINER—
Jun 22, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 24, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance